News

Warwick Reaches Definitive Agreement to Acquire IDC

India's Sun Pharma Wins over Taro with Higher Offer

Brenntag Grows in Q2 2012 in More Difficult Market Conditions

Neuland Labs Reports Q1 2013 Financial Results

Oxea Expands Production Capacities for Carboxylic Acids

Oxea today has once again expanded its production capacity for carboxylic acids.

Argentina's YPF Says Q2 Net Profit Up 8%

US Seeks Info on Drug Diversion from AmerisourceBergen

Chemistry and the Olympics: The Olympic Torch Relay

Jennifer Stewart New VP & Managing Director at Eastman EMEA

Hikal Q1 Net Sales Up by 16%

Invista Acquires Rights for PTA, PET in Europe, the Middle East and Africa

Huntsman to Expand its US MDI Manufacturing Plant

Novasep Invests €3 Million to Boost its HPAPI Manufacturing Capabilities

AstraZeneca Buys Equal Say over Amylin Drugs

Arkema Gains Foothold in Brazil in Acrylic Specialties

Eli Lilly Raises 2012 Net Profit Forecast

Arkema Closes Acquisition of Hipro Polymers and Casda Biomaterials

Novo Nordisk Raises Targets on Victoza, Insulin Demand

Arkema Confirms its High Profitability Level

Borealis Delivers Solid Profits in a Difficult Market Environment

Oxea Expands its Portfolio with New Special Alcohols

Chemical manufacturer Oxea announced that it is expanding its product portfolio by offering a broader range of higher alcohols.

Altana Reports Sales Increase in the First Half of 2012

Ashland: Shana’a to Lead Technology and Growth for Specialty Ingredients

Fire at Chevron's California Refinery Spikes Gasoline Prices

Warner Chilcott Ends Sale Talks, to Pay $1 Billion Dividend

Pfizer Settles Foreign Bribery Case with US Government

Ineos Broadens Product Range

Intergraph and Siemens Energy Extend Global Alliance Agreement

Air Products to Build new Advanced Gasification Energy-from-Waste Facility

Lanxess Confirms 2012 Forecast

Fire Blazes at Chevron's California Refinery

Nigeria's Oil Law is Test for Jonathan Presidency

Momenta Set Back as Court Lifts Blood Clot Drug Halt

Petrobras Posts First Loss in 13 Years

Givaudan's H1 Margin Slip Gives Rise to Dividend Fear